OPKO Health, Inc. Equity Securities, FV-NI, Realized Gain (Loss)
OPKO Health, Inc. (OPK) reported Equity Securities, FV-NI, Realized Gain (Loss) of $0 for the 6-month period ending 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2026-08-28
- OPKO Health, Inc. equity securities, fv-ni, realized gain (loss) for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- OPKO Health, Inc. equity securities, fv-ni, realized gain (loss) for the quarter ending 2026-03-31 was $0.00.
- OPKO Health, Inc. equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-12-31 was -$386.00K.
- OPKO Health, Inc. equity securities, fv-ni, realized gain (loss) for the quarter ending 2025-09-30 was -$7.88M.
- OPKO Health, Inc. equity securities, fv-ni, realized gain (loss) for fiscal 2025 was -$4.32M.
- OPKO Health, Inc. equity securities, fv-ni, realized gain (loss) for fiscal 2024 was -$54.03M.
- OPKO Health, Inc. equity securities, fv-ni, realized gain (loss) for fiscal 2023 was $0.00.
- OPKO Health, Inc. equity securities, fv-ni, realized gain (loss) for fiscal 2022 was $0.00.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 3 month as first filed | Equity Securities, FV-NI, Realized Gain (Loss) 6 month | Equity Securities, FV-NI, Realized Gain (Loss) 6 month as first filed | Equity Securities, FV-NI, Realized Gain (Loss) 9 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month as first filed | Equity Securities, FV-NI, Realized Gain (Loss) 12 month | Equity Securities, FV-NI, Realized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $0.00 10-Q/A · filed 2026-08-28 | -$386.00K derived: sum of 3 quarters · filed 2026-08-28 | -$8.26M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2026-03-31 | $0.00 10-Q/A · filed 2026-08-28 | -$386.00K derived: sum of 2 quarters · filed 2026-08-28 | -$8.26M derived: sum of 3 quarters · filed 2026-08-28 | -$386.00K derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-12-31 | -$386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$8.26M derived: sum of 2 quarters · filed 2026-02-26 | -$386.00K derived: sum of 3 quarters · filed 2026-08-28 | -$4.32M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | -$7.88M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2025-10-29 | $0.00 derived: sum of 2 quarters · filed 2026-08-28 | -$3.94M 10-Q · filed 2025-10-29 | -$57.93M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2025-06-30 | $7.88M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2026-08-28 | $3.94M 10-Q/A · filed 2026-08-28 | -$3.94M 10-Q · filed 2025-07-31 | -$50.06M derived: sum of 3 quarters · filed 2026-08-28 | -$50.09M derived: sum of 4 quarters · filed 2026-08-28 | |||
| 2025-03-31 | -$3.94M 10-Q/A · filed 2026-08-28 | -$57.93M derived: sum of 2 quarters · filed 2026-08-28 | -$57.96M derived: sum of 3 quarters · filed 2026-08-28 | -$57.96M derived: sum of 4 quarters · filed 2026-08-28 | ||||
| 2024-12-31 | -$54.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$54.03M derived: sum of 2 quarters · filed 2026-02-26 | -$54.03M derived: sum of 3 quarters · filed 2026-02-26 | -$54.03M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$30.00K derived: sum of 2 quarters · filed 2025-10-29 | -$30.00K 10-Q · filed 2025-10-29 | -$30.00K derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $0.00 10-Q · filed 2025-07-31 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | |||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-01 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | ||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 | ||||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | |||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 derived: sum of 3 quarters · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | -$5.96M derived: sum of 4 quarters · filed 2024-03-01 | ||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | -$5.96M derived: sum of 3 quarters · filed 2024-03-01 | -$5.96M derived: sum of 4 quarters · filed 2024-03-01 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | -$5.96M derived: sum of 2 quarters · filed 2024-03-01 | -$5.96M derived: sum of 3 quarters · filed 2024-03-01 | -$5.96M derived: sum of 4 quarters · filed 2024-03-01 | ||||
| 2021-12-31 | -$5.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$5.96M derived: sum of 2 quarters · filed 2024-03-01 | -$5.96M derived: sum of 3 quarters · filed 2024-03-01 | -$2.98M 10-K · filed 2024-03-01 | $2.98M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $2.98M 10-Q · filed 2022-11-08 | -$2.98M 10-Q · filed 2021-10-28 | $2.98M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.98M 10-Q · filed 2022-08-04 | $2.98M derived: sum of 3 quarters · filed 2023-02-27 | $13.30M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $2.98M 10-Q · filed 2022-05-09 | $2.98M derived: sum of 2 quarters · filed 2023-02-27 | $13.30M derived: sum of 3 quarters · filed 2023-02-27 | $13.30M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $10.32M derived: sum of 2 quarters · filed 2023-02-27 | $10.32M derived: sum of 3 quarters · filed 2023-02-27 | $10.32M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $10.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $10.32M derived: sum of 2 quarters · filed 2021-10-28 | $10.32M 10-Q · filed 2021-10-28 | $8.96M 10-Q · filed 2020-10-29 | $27.51M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | $5.91M 10-Q · filed 2020-07-31 | $17.18M derived: sum of 3 quarters · filed 2022-03-01 | $5.46M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-04-28 | -$9.88M 10-Q · filed 2020-05-06 | $17.18M derived: sum of 2 quarters · filed 2022-03-01 | $5.46M derived: sum of 3 quarters · filed 2022-03-01 | -$1.41M derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $17.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $5.46M derived: sum of 2 quarters · filed 2022-03-01 | -$1.41M derived: sum of 3 quarters · filed 2022-03-01 | $0.00 10-K · filed 2022-03-01 | -$7.44M 10-K · filed 2020-03-02 | |||
| 2019-09-30 | -$11.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$18.59M derived: sum of 2 quarters · filed 2019-11-05 | -$17.18M 10-Q · filed 2019-11-05 | -$27.81M derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2019-06-30 | -$6.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$5.46M 10-Q · filed 2019-08-07 | -$16.08M derived: sum of 3 quarters · filed 2021-02-18 | -$16.86M derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2019-03-31 | $1.41M 10-Q · filed 2019-05-08 | -$9.21M derived: sum of 2 quarters · filed 2021-02-18 | -$9.99M derived: sum of 3 quarters · filed 2021-02-18 | |||||
| 2018-12-31 | -$10.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$11.40M derived: sum of 2 quarters · filed 2021-02-18 | -$113.00K 10-K · filed 2021-02-18 | $2.75M 10-K · filed 2019-03-01 | ||||
| 2018-09-30 | -$780.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $10.51M 10-Q · filed 2018-11-09 | ||||||
| 2018-06-30 | $11.29M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |